Tag: Pfizer
Merck, Pfizer’s Wyeth Settle Vaccine Patent Case
Merck Sharp & Dohme Corp and Pfizer's Wyeth subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and...
Pfizer To Buy Cancer Drugmaker Trillium For $2.3B
Pfizer stated on Monday, August 23, it would buy Canadian drug developer Trillium Therapeutics in a US$2.26 billion deal to strengthen its arsenal of...
UK Accuses Pfizer & Flynn Of Overcharging NHS For Anti-Epilepsy Drugs
Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the National Health Service (NHS) for vital anti-epilepsy...
Pfizer, Johnson & Johnson Settle Remicade Antitrust Suit
Pfizer settled with Johnson & Johnson, ending a four-year battle over J&J’s alleged use of exclusionary contracts to block biosimilar competition to its immunosuppressive...
Pfizer Pays To Exit EpiPen Price-Gouging Case
Pfizer and two subsidiaries will pay $345 million to escape antitrust litigation over an alleged scheme to gouge purchasers of the EpiPen, a lifesaving...
Request To Create California Subclass In Lipitor Antitrust Case Refused
A federal judge has refused to create a California subclass within a nationwide proposed class action accusing Pfizer of obtaining a fraudulent patent and...
Pfizer To Grow COVID-19 Vaccine Production With Sanofi Deal
Sanofi has agreed to produce millions of doses of BioNTech and Pfizer’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts, reported Bloomberg.
The...
FTC Imposes Conditions On Pfizer’s Upjohn & Mylan Deal
Pharmaceutical companies Pfizer and Mylan have agreed to divest assets and abide by other conditions to settle Federal Trade Commission (FTC) charges that the...
Refusals to License Patents under Australia’s “New” Unilateral Conduct Prohibition
By Arlen Duke & Rhonda L. Smith (University of Melbourne)*
Both intellectual property (“IP”) and competition policies aim to provide an incentive for creation/innovation. However,...
UK’s CMA Told To Review Evidence Against Pfizer And Flynn
Britain’s competition regulator has been told to review its evidence against US drugmaker Pfizer and Flynn Pharma in the UK as it seeks to...
